Disruption of mitochondrial membrane potential coupled with alterations in cardiac biomarker expression as early cardiotoxic signatures in human ES cell–derived cardiac cells

Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes

(2017) Jochem Louisse et al.   TOXICOLOGY IN VITRO

A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours

(2016) Juan Li et al.   JOURNAL OF DRUG TARGETING

Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats

(2016) Naif O. Al-Harbi   TOXICOLOGY MECHANISMS AND METHODS

Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats

(2016) Naif O. Al-Harbi   TOXICOLOGY MECHANISMS AND METHODS

Drug-induced mitochondrial dysfunction and cardiotoxicity

(2015) Zoltán V Varga et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury

(2015) M J Cross et al.   BRITISH JOURNAL OF PHARMACOLOGY

Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells

(2015) Gustav Holmgren et al.   TOXICOLOGY

Differentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors

(2013) Harsha Pawani et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy

(2013) Filipa S. Carvalho et al.   MEDICINAL RESEARCH REVIEWS

Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection

(2012) Martin Štěrba et al.   ANTIOXIDANTS & REDOX SIGNALING

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

(2011) HG Laverty et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cardiovascular Complications of Cancer Therapy

(2009) Edward T.H. Yeh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

(2008) Fotiní Dodos et al.   Clinical Research in Cardiology